0001578563-19-000018.txt : 20190529
0001578563-19-000018.hdr.sgml : 20190529
20190529170302
ACCESSION NUMBER: 0001578563-19-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190524
FILED AS OF DATE: 20190529
DATE AS OF CHANGE: 20190529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calias Pericles
CENTRAL INDEX KEY: 0001746282
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 19862918
MAIL ADDRESS:
STREET 1: C/O CERECOR INC.
STREET 2: 400 EAST PRATT STREET, SUITE 606
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerecor Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-05-24
0
0001534120
Cerecor Inc.
CERC
0001746282
Calias Pericles
C/O CERECOR INC.
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
0
1
0
0
Chief Scientific Officer
Common Stock
2019-05-24
4
A
0
45000
0
A
45000
D
Stock Option (Right to Buy)
4.98
2019-05-24
4
A
0
25000
0
A
2029-05-24
Common Stock
25000
25000
D
Stock Option (Right to Buy)
4.26
2028-07-16
Common Stock
80000
80000
D
Stock Option (Right to Buy)
6.22
2029-04-01
Common Stock
175000
175000
D
The restricted stock units vest in four equal installments beginning on July 16, 2019, provided the Reporting Person is then still providing continuous service as an employee, director or consultant.
One-fourth of the shares subject to the stock option will vest on July 16, 2019, and the remaining three-fourths of the shares subject to the stock option will vest in substantially equal monthly installments over the following 36 months, provided the Reporting Person is then still providing continuous service as an employee, director or consultant.
One-fourth of the shares subject to the stock option will vest on April 1, 2020, and the remaining three-fourths of the shares subject to the stock option will vest in substantially equal monthly installments over the following 36 months.
/s/ Donald R. Reynolds, by Power of Attorney
2019-05-29